Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.

Ephross SA, Sinclair SM.

Headache. 2014 Jul-Aug;54(7):1158-72. doi: 10.1111/head.12375. Epub 2014 May 7.

PMID:
24805878
3.

Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.

Martin VT, Ballard J, Diamond MP, Mannix LK, Derosier FJ, Lener SE, Krishen A, McDonald SA.

J Womens Health (Larchmt). 2014 May;23(5):389-96. doi: 10.1089/jwh.2013.4577. Epub 2014 Feb 28.

4.

Canadian Headache Society Guideline: acute drug therapy for migraine headache.

Worthington I, Pringsheim T, Gawel MJ, Gladstone J, Cooper P, Dilli E, Aube M, Leroux E, Becker WJ; Canadian Headache Society Acute Migraine Treatment Guideline Development Group.

Can J Neurol Sci. 2013 Sep;40(5 Suppl 3):S1-S80. Review.

PMID:
23968886
5.

Sumatriptan plus naproxen for acute migraine attacks in adults.

Law S, Derry S, Moore RA.

Cochrane Database Syst Rev. 2013 Oct 21;10:CD008541. doi: 10.1002/14651858.CD008541.pub2. Review.

PMID:
24142431
6.

Naproxen with or without an antiemetic for acute migraine headaches in adults.

Law S, Derry S, Moore RA.

Cochrane Database Syst Rev. 2013 Oct 20;10:CD009455. doi: 10.1002/14651858.CD009455.pub2. Review.

PMID:
24142263
7.

Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: a randomized study.

Silberstein S, McDonald SA, Goldstein J, Aurora S, Lener SE, White J, Runken MC, Saiers J, Derosier F, Lipton RB.

Cephalalgia. 2014 Apr;34(4):268-79. doi: 10.1177/0333102413508242. Epub 2013 Oct 9.

PMID:
24108307
8.

SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.

Cady R, O'Carroll P, Dexter K, Freitag F, Shade CL.

Headache. 2014 Jan;54(1):67-79. doi: 10.1111/head.12211. Epub 2013 Sep 10.

PMID:
24021029
9.

Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.

Cady R, Nett R, Dexter K, Freitag F, Beach ME, Manley HR.

Headache. 2014 Jan;54(1):80-93. doi: 10.1111/head.12210. Epub 2013 Sep 10.

PMID:
24020994
10.

Ictal adiponectin levels in episodic migraineurs: a randomized pilot trial.

Peterlin BL, Tietjen GE, Gower BA, Ward TN, Tepper SJ, White LW, Dash PD, Hammond ER, Haythornthwaite JA.

Headache. 2013 Mar;53(3):474-90. doi: 10.1111/head.12071.

11.

Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-over study assessing cognitive function.

Edwards KR, Rosenthal BL, Farmer KU, Cady RK, Browning R.

Headache. 2013 Apr;53(4):656-64. doi: 10.1111/head.12052. Epub 2013 Feb 13.

PMID:
23406052
12.

A randomized controlled trial of a comprehensive migraine intervention prior to discharge from an emergency department.

Friedman BW, Solorzano C, Norton J, Adewumni V, Campbell CM, Esses D, Bijur PE, Solomon S, Lipton RB, John Gallagher E.

Acad Emerg Med. 2012 Oct;19(10):1151-7. doi: 10.1111/j.1553-2712.2012.01458.x. Epub 2012 Sep 20.

13.

Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine.

Derosier FJ, Lewis D, Hershey AD, Winner PK, Pearlman E, Rothner AD, Linder SL, Goodman DK, Jimenez TB, Granberry WK, Runken MC.

Pediatrics. 2012 Jun;129(6):e1411-20. doi: 10.1542/peds.2011-2455. Epub 2012 May 14.

14.

The development of a survey to measure completeness of response to migraine therapy.

Coon CD, Fehnel SE, Davis KH, Runken MC, Beach ME, Cady RK.

Headache. 2012 Apr;52(4):550-72. doi: 10.1111/j.1526-4610.2012.02099.x.

PMID:
22486740
15.

Pharmacological synergy: the next frontier on therapeutic advancement for migraine.

Blumenfeld A, Gennings C, Cady R.

Headache. 2012 Apr;52(4):636-47. doi: 10.1111/j.1526-4610.2011.02058.x. Epub 2012 Jan 6. Review.

PMID:
22221151
16.

Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.

Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.

Headache. 2012 Apr;52(4):530-43. doi: 10.1111/j.1526-4610.2011.02039.x. Epub 2011 Nov 21.

PMID:
22103635
17.

Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.

Allais G, Castagnoli Gabellari I, Rolando S, Benedetto C.

Expert Rev Neurother. 2011 Oct;11(10):1383-7. doi: 10.1586/ern.11.123. Review.

PMID:
21955195
18.

Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.

Landy S, Hoagland R, Hoagland NA.

Headache. 2012 Jan;52(1):133-9. doi: 10.1111/j.1526-4610.2011.01992.x. Epub 2011 Aug 29.

PMID:
21883200
19.

Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents.

McDonald SA, Hershey AD, Pearlman E, Lewis D, Winner PK, Rothner D, Linder SL, Runken MC, Richard NE, Derosier FJ.

Headache. 2011 Oct;51(9):1374-87. doi: 10.1111/j.1526-4610.2011.01965.x. Epub 2011 Jul 28.

PMID:
21797863
20.

Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response survey.

Cady R, Banks J, Nett RB, Goldstein J, Bennett N, Turner IM, Ruoff GE, Landy SH, Farmer K, Juhász M, Tarrasch J, Runken MC.

Headache. 2011 Jun;51(6):961-70. doi: 10.1111/j.1526-4610.2011.01912.x. Epub 2011 May 17.

PMID:
21592098
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk